0

The full content of Annals is available to subscribers

Subscribe/Learn More  >
Position Papers |

Therapeutic Substitution and Formulary Systems

[+] Article and Author Information

Requests for Reprints: Linda Johnson White, Director, Department of Scientific Policy, American College of Physicians, Independence Mall West, Sixth Street at Race, Philadelphia, PA 19106-1572.


© 1990 American College of PhysiciansAmerican College of Physicians


Ann Intern Med. 1990;113(2):160-163. doi:10.7326/0003-4819-113-2-160
Text Size: A A A
This excerpt has been provided in the absence of an abstract.

The practice of therapeutic drug substitution has become common throughout the United States, often without the awareness of many physicians. It occurs to some extent in more than 52% of the nation's acute care hospitals and more than 30% of health maintenance organizations (HMOs) (1, 2). Therapeutic substitution entails dispensing a drug different in chemical structure from the one originally prescribed. The substitute must be from the same therapeutic class (therapeutic alternate) and have the same pharmacodynamic and pharmacokinetic properties (for example, cefazolin for cefotaxime; cimetidine for ranitidine).

Therapeutic substitution originates in an institution's formulary system. Arising from the need

...

Topics

formulary

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Letters

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Comments

Submit a Comment
Submit a Comment

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

Toolkit

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Advertisement
Related Articles
Topic Collections
PubMed Articles
Impact of Drug Policy on Regional Trends in Ezetimibe Use. Circ Cardiovasc Qual Outcomes Published online Jun 3, 2014.;

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)